David Ebersman, the former executive vice president and CFO of Genentech, the biotechnology firm recently acquired by Roche, will take over as CFO of Facebook from September, the Palo Alto, California-based Facebook said.
Ebersman will report to Facebook chief executive and founder Mark Zuckerberg and will oversee the company’s finance, accounting, investor relations, and real estate functions, Facebook said in a statement on Monday.
Ebersman replaces Gideon Yu, who left Facebook in March. He will also join the executive management team, which directs all aspects of company strategy, planning and operations, it said.
“(Ebersman) was Genentech’s CFO while revenue tripled, and his success in scaling the finance organisation of a fast growing company will be important to Facebook,” Zuckerberg said.
No profits reported
While its number of users has grown at an amazing clip, Facebook, unlike other Web giants such as Amazon, eBay, Google and Yahoo!, has yet to prove how it is going to turn traffic into cash.
A Russian Internet company, Digital Sky Technologies (DST), invested $US200 million ($A247.68 million) in Facebook in May in a deal that values the social networking giant at $US10 billion ($A12.38 billion).
DST’s purchase of a 1.96 per cent stake in preferred stock in Facebook was the largest cash-raising exercise by the social network in two years.
US computer software giant Microsoft bought a 1.6 per cent stake in Facebook for $US240 million ($A297.21 million) in 2007, a deal that at the time valued the company at $US15 billion ($A18.58 billion).